Dépistage de masse du Covid-19 : quelles leçons tirer des récentes expériences ? [Mass testing for Covid-19 : what can we learn from real-world implementation ?]
Fiche du document
5 mai 2021
- doi: 10.53738/REVMED.2021.17.737.0877
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.737.0877
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33950589
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4B4F0F36BD6A7
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Spectateurs Public Auditoire Assistance (public) Visiteurs Fréquentation AudienceCiter ce document
Y. Sancosme et al., « Dépistage de masse du Covid-19 : quelles leçons tirer des récentes expériences ? [Mass testing for Covid-19 : what can we learn from real-world implementation ?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.737.0877
Métriques
Partage / Export
Résumé
While several modelling studies suggest mass testing for SARS-CoV-2 could be effective, real-world attempts at implementation have not been sufficient to evaluate its contribution to controlling the pandemic. To slow the spread of the virus, a mass-testing campaign would need frequent testing over a prolonged period with high rates of participation, all while maintaining public health measures. Screening seems more useful for targeted populations or high-risk events (businesses, teaching facilities, public or private institutions, sporting or cultural events). With their low cost and rapid results, rapid tests should be favored for these interventions.